A new complex, manganese(II) azide complex with N-methylimidazole, has been synthesized and characterized by elemental analysis, IR spectra and single crystal X-ray studies. Absorption spectroscopy, emission spectroscopy, viscosity measurements and CD spectroscopy have been used to investigate the binding of the complex with calf thymus DNA (CT-DNA). The intrinsic binding constant Kb of the complex with DNA was obtained by electronic absorption titration; the value is consistent with the result by fluorescence titration method. The spectroscopic studies together with viscosity measurements support the claim that the title complex bonds to CT-DNA by a groove mode. Control cleavage experiments using pBR 322 plasmid DNA which suggest minor groove binding for the complex.
Introduction
Studies on the interaction of small molecules with DNA continue to attract considerable attention due to their importance in cancer therapy and molecular biology. [1] [2] [3] In this respect, transition metal complexes have attracted special attention due to their unique spectroscopic and electrochemical signatures. [4] [5] [6] The interest in the DNA recognition by transition metal complexes has been substantially aided by the DNA cleaving ability of some of these metal complexes. [7] [8] [9] The DNA cleavage activity of such complexes can be targeted towards different constituents of DNA that include the heterocyclic bases, deoxyribose sugar moiety and phosphodiester linkage. Artificial metallonucleases have proven to be efficient tools for the footprinting and sequence-specific targeting of nucleic acids. [10] [11] [12] They are composed of a transition or lanthanide metal ion and a ligand which plays two major roles, it modulates the reactivity of the metal ion and, by interacting with the nucleic acid, it delivers the reactive metal ion species to the vicinity of the sensitive functionalities of the biopolymer.
In addition, imidazoles are common components of a large number of natural products and pharmacologically active molecules. 13 The imidazole ring functions as a ligand toward transition metal ions in a number of biologically important systems. 13, 14 These facts make imidazole and its derivatives important target analytes. It was reported that the metal coordination compound of imidazole could inhibit tumor growth by interacting with DNA. [15] [16] [17] For example, the nickel(II) coordination compounds of imidazole can bind with DNA and have been regarded as efficient anti-tumor drugs. 15 Tamura reported that Cu(OAc)2(Im)2 also has the anti-tumor effect. 17 It was also reported that synthesized zinc(II) porphyrin conjugate with an appended pyrene subunit exhibits significant fluorescence sensing toward imidazole derivatives. 13 As one of the several transition metal elements, manganese has been found to play an important role in the metabolism process in the biological system and in the redox process in the organism. [18] [19] [20] However, DNA binding and hydrolytic activity of imidazole manganese complex as a nuclease have not been reported in the literature.
We thus aimed to discover a new DNA binding and cleavage reagent. In this research, the two-dimensional manganese(II) azide complex with N-methylimidazole was synthesized according to our previous report. 21 The interaction between the complex and DNA has been studied by UV, fluorescence, CD spectroscopy, and viscosity measurements. The experimental results have proved that the compound could interact with DNA by groove binding. Agarose gel electrophoresis experiments showed that the complex can effectively cleave plasmid DNA. The results should be valuable in understanding the mode of the complex with DNA as well as in laying a foundation for the rational design of novel, powerful agents for probing and targeting nucleic acids.
Experimental

Materials
Calf thymus DNA (CT-DNA) and N-methylimidazole were purchased from Sigma (USA). All other chemicals were local products of analytical grade. All the experiments involving interaction of the complexes with CT-DNA were carried out in doubly distilled water buffer containing 5 mM Tris and 50 mM NaCl and adjusted to pH 7.2 with hydrochloric acid. A solution of CT-DNA gave a ratio of UV absorbance at 260 and 280 nm of about 1.8 -1.9, indicating that the CT-DNA was sufficiently free of protein. 22 The CT-DNA concentration per nucleotide was determined spectrophotometrically by employing an extinction coefficient of 6600 M -1 cm -1 at 260 nm.
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Syntheses
The title complex was prepared according to the literature method. 21 
Instrumentation
Carbon, hydrogen, and nitrogen were analyzed on an Elemental Vario EL analyzer. Infrared spectra (4000 -400 cm -1 ) were determined with KBr disks on a Thermo Mattson FTIR spectrometer. The UV-visible spectra were recorded on a Varian Cary 100 Conc. spectrophotometer. The fluorescence spectra were recorded on a Hitachi RF-4500 spectrofluorophotometer.
The CD spectra were recorded on an Olis RSM 1000 at increasing complex/DNA ratio (r = 0.0, 0.5). Each sample solution was scanned in the range of 220 -320 nm. A CD spectrum was generated which represented the average of three scans from which the buffer background had been subtracted. The concentration of DNA was 1.0 ¥ 10 -4 M.
DNA-binding experiments and cleavage experiments
The complexes were dissolved in Tris-HCl buffer (5 mM TrisHCl, 50 mM NaCl, pH 7.2) at concentrations of 1.0 ¥ 10 -5 M. An absorption titration experiment was performed by maintaining 10 mM compounds and varying the concentration of nucleic acid. While the absorption spectra were being measured, an equal amount of CT-DNA was added to both the compound solution and the reference solution to eliminate the absorbance of CT-DNA itself.
Viscosity experiments were conducted on an Ubbelodhe viscometer, immersed in a thermostated water-bath maintained at 25 ± 0.1˚C. Titrations were performed for the complex (0.5 -3 mM), and the compound was introduced into the CT-DNA solution (5 mM) present in the viscometer. Data were presented as (h/h0) 1/3 vs. the ratio of the concentration of the compound to CT-DNA, where h is the viscosity of CT-DNA in the presence of the compound and h0 is the viscosity of CT-DNA alone. Viscosity values were calculated from the observed flow time of CT-DNA containing solutions corrected from the flow time of buffer alone (t0), h = t -t0. 23 The cleavage of plasmid DNA was monitored using agarose gel electrophoresis. Supercoiled pBR322 DNA (0.2 mg) in TrisHCl buffer (10 mM, pH 7.5) with 18 mM NaCl was treated with the complex. Concentration of the complex was also varied from 0 to 10 mM. The samples were incubated for 60 min at 37˚C. A loading buffer containing 0.25% bromophenol blue, 40% w/v sucrose and 0.5 M EDTA was added and the electrophoresis of the DNA cleavage products was performed on 0.8% agarose gel containing 0.5 mg/mL ethidium bromide. The gels were run at 50 V for 3 h in Tris-boric acid-ethylenediamine tetraacetic acid (TBE) buffer and the bands were photographed by a gel documentation system.
Cytotoxicity assay
Tumor cells used were grown in cytotoxicity assay RPMI-1640 medium supplemented with 10% (v/v) fetal bovine serum, 2 mM glutamine, 100 U/mL penicillin, and 100 mg/mL streptomycin in a highly humidified atmosphere of 95% air with 5% CO2 at 310 K. The cytotoxicity of the compound against MFC (mouse proventriculus squamous carcinoma) cell line was examined by the microculture tetrozolium (MTT) assay. In brief, cells were seeded in 96-well flat-bottomed microtiter plates (3000 -5000 cells/well) and were incubated for 48 h with drugs, applied as serial 1:2 dilutions (100 L/well), ranging from 20 mmol/L down to 0.2 mmol/L or 0.1% DMSO as control.
Twenty microliters of MTT (5 mg/mL) were added to each well and samples were incubated for 4 h at 37˚C. The formazan product was dissolved by adding 100 mL DMSO to each well, and the absorbance of each cell was measured by UV spectrometry at 570 nm. All measurements were performed in triplicate and each experiment was repeated at least 3 times. The IC50 was calculated from the 50% formazan formation compared with the control without the addition of drugs.
Results and Discussion
Crystal structure of the complex
The title complex was crystallized in the monoclinic system, space group P21/n. A view of the ORTEP plot of the title complex is shown in Fig. 1 . Each manganese atom is placed in a centro-symmetric octahedral environment. The coordination polyhedron is formed by two N-methylimidazole and four azido ligands coordinated in a trans-arrangement with the Mn-N bond lengths in the range from 2.2394(12) to 2.2456(12)Å. The axial Mn-N(3), Mn-N(1) and Mn-N(5) bond lengths are 2.2456(12), 2.2315(11) and 2.2394(12)Å, respectively. Each of the four azide ligands acts as a m1,3 bridge with each one of the neighboring manganese atoms, giving an extended twodimensional layer (Fig. 2) .
Infrared spectra
The spectra of the N-methylimidazole exhibit nC=N vibration bands at 1563 cm -1 and nC-N vibrations at the 1279 cm -1 , in the complex the nC=N and the nC-N vibration were red shifted to 1531 and 1227 cm -1 , respectively. It can be found that the characteristic absorption peaks of azide nN3 appeared at 2080 cm -1 in the complex. The spectral change demonstrates that the title compound formed.
Electronic absorption titration
Hypochromicity in the absorption spectra generally accompanies the binding of molecules to DNA. The extent of spectral change is related to the strength of binding. 24 The absorption spectra of the complex in the absence and presence of CT-DNA (at a constant concentration of the complex) are given in Fig. 3 . It can be seen that the complex exhibited intense absorption bands in the UV region, which are attributed to intraligand p-p* transition of the coordinated groups. In the presence of DNA, the absorption bands of the title complex at about 211 nm exhibited hypochromism of about 58.5% and bathochromism of 5 nm. The spectroscopic changes suggest Fig. 1 The molecular structure of the title complex with the atomic numbering scheme. 21 that the complex have interacted with DNA.
In order to affirm quantitatively the affinity of the complex bound to DNA, we obtained the intrinsic binding constants Kb of the complex with DNA was obtained by monitoring the changes in absorbance at 211 nm for the title complex with increasing concentration of DNA using the following Eq. (1). 25 [DNA]/(ea -ef) The observed binding constant is more in keeping with the groove binding with DNA, as observed in the literature. 28 
Fluorescence studies
The complex can emit fluorescence in Tris buffer at ambient temperature, with a maximum appearing at about 396 nm. As shown in Fig. 4 , the fluorescence intensity of the complex increased steadily with the increasing concentration of the CT-DNA, and emission maximum shift by 8 nm to longer wavelength (404 nm) for the compound. This effect happens because, in the presence of DNA, the metal complex is bound in a relatively non-polar environment compared to water. The increase in the fluorescence intensity is less than that for the intercalators.
To affirm the binding constant we have obtained from the UV results, we calculate the intrinsic binding constant here by fluorescence titration method also, 29 and the value is 1.3 ¥ 10 5 . Fixed amounts (10 mM) of the complexes were titrated with increasing amounts of CT-DNA. The concentration of the bound compound was calculated using the following equation:
Ct is the total compound concentration, F the observed fluorescence emission intensity at given CT-DNA concentration, F0 the intensity in the absence of CT-DNA, and Fmax the fluorescence of the totally bound compound. The concentration of the free compound Cf is equal to (Ct -Cb). Binding data were cast into the form of a Scathchard plot 30 
of r/Cf vs. r, where r is the binding ratio Cb/[CT-DNA].
All experiments were conducted at 20˚C in a buffer containing 5 mM Tris-HCl (pH 7.2) and 50 mM NaCl concentrations.
CD spectral studies
CD (circular dichroic) spectral techniques give us useful information on how the conformation of DNA is influenced by the binding of the metal complex to DNA. The observed CD spectrum of CT-DNA consists of a positive band at 277 nm due to base stacking and a negative band at 245 nm due to helicity, which is characteristic of DNA in the right-handed B form. The interaction of the complex with DNA induces a change in CD spectrum of B DNA (Fig. 5) . The intesities of both the negative and positive bands decrease significantly with increasing the concentration of the complex. This suggests that the DNA binding of the complex induces certain conformational changes, such as the conversion from a more B-like to a more C-like structure within the DNA molecule. 31 Interaction with cations effectively screens the negative charge on N(7) base sites as well as phosphate oxygens simultaneously, both along the deoxyribophosphate backbone and in the groove of the helix to promote such as trans conformational change. 32 
Viscosity studies
Hydrodynamic methods that are sensitive to length are regarded the least ambiguous and most critical tests of a binding mode in solution in the absence of crystallographic structural data. Intercalating agents are expected to elongate the double helix to accommodate the ligands in between the base leading to an increase in the viscosity of DNA. In contrast, complexes that bind exclusively in the DNA grooves by partial and/or nonclassical intercalation, under the same conditions, typically cause less pronounced (positive or negative) or no change in DNA solution viscosity. 33 The values of (h/h0) 1/3 were plotted against [complex]/[DNA] (Fig. 6) . The results reveal that the complex causes almost no increase in DNA viscosity, which is consistent with DNA groove binding suggested above. 34 The increased degree of viscosity may depend on its affinity to DNA, which is consistent with our foregoing hypothesis.
Cleavage of plasmid pBR322 DNA
It is known that DNA cleavage is controlled by relaxation of supercoiled circular conformation of pBR322 DNA nicked circular and/or linear conformations. When electrophoresis is applied to circular plasmid DNA, the fastest migration will be observed for DNA of closed circular conformations (Form I). If one strand is cleaved, the supercoil will relax to produce a slower-moving nicked conformation (Form II). If both strands are cleaved, a linear conformation (Form III) will be generated that migrates in between. 35, 36 Figure 7 shows the results of gel electrophoretic separations of plasmid pBR322 DNA induced by an increasing amount of title complex. The supercoiled (form I) DNA was cleaved to form the mixture of form II and form III. The formation of form III began to appear in the presence of the complexes as 4 mmol (lane 3). Form I to form II and form III became distinct with the increase in concentration of the complex (lanes 4 and 5). This phenomena imply that the complex induces intensively the cleavage of plasmid pBR322 DNA.
Bioassay in vitro
We completed the elementary work to evaluate the biological activities of the title complex, and we just investigate that the inhibiting effects of the complex against MFC. But the results we obtained are not satisfying: the complex does not exhibit better activity against MFC-5 compared to the free ligand. Our further work is undergoing to investigating the cytotoxicity of the complex against other cell lines.
Conclusion
The novel 2D water-soluble manganese complex has been synthesized and characterized. The DNA-binding and cleavage property of the complex was examined by absorption, fluorescence, CD spectra, viscosity and agarose gel electrophoresis measurements. Experimental results indicate that the complex can bond to CT-DNA in the mode of groove binding, and will be capable of cleaving pBR322 DNA. Furthermore, the effects of the complex on cell viability were tested using the MTT assay. The results indicated that the title complex does not exhibit better effect on MFC. Further studies will be needed to understand the selectivity of the complex to other cells. 
